The "Amyotrophic Lateral Sclerosis - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Amid the COVID-19 crisis, the global market for Amyotrophic Lateral Sclerosis estimated at US$339.2 Million in the year 2020, is projected to reach a revised size of US$1.2 Billion by 2027, growing at a CAGR of 19.2% over the period 2020-2027.
The U.S. Market is Estimated at $100.6 Million, While China is Forecast to Grow at 18.4% CAGR
The Amyotrophic Lateral Sclerosis market in the U.S. is estimated at US$100.6 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$199.1 Million by the year 2027 trailing a CAGR of 18.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 17.1% and 16.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 14.1% CAGR.
Select Competitors (Total 31 Featured):
AB Science SA
Brainstorm Cell Therapeutics Inc.
F. Hoffmann-La Roche AG
Genervon Biopharmaceuticals LLC
Ionis Pharmaceuticals, Inc.
Kringle Pharma Inc.
Mitsubishi Tanabe Pharma Corporation
Valeant Pharmaceuticals International, Inc.
ViroMed Co., Ltd.
Key Topics Covered:
II. EXECUTIVE SUMMARY
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
III. MARKET ANALYSIS
Total Companies Profiled: 31
For more information about this report visit https://www.researchandmarkets.com/r/ay1mka
View source version on businesswire.com: https://www.businesswire.com/news/home/20210408005378/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900